Stockreport

OptimizeRx Corp (OPRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]

OptimizeRx Corporation  (OPRX) 
NASDAQ:AMEX Investor Relations: optimizerx.com/investors
PDF This article first appeared on GuruFocus Fourth Quarter Revenue: $32.2 million. Full Year Revenue: $109.4 million. Fourth Quarter Adjusted EBITA: $12 million. F [Read more]